This array of proteins contains epitopes for CD4+ and CD8+ T cells, facilitating MHC classes I and II presentation, and promoting a broad anti-tumour immune response that may reduce chances of tumour escape and development of resistance [82, 83]. Here, CD8A is linked to neoplasm.